Singapore-based Everlife Holdings, a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Research Instruments Group (RI), a leading provider of scientific and laboratory instrumentation in Singapore, Malaysia, Thailand and Vietnam. 

Founded in 1989, the group has established itself as a trusted partner to the life science and scientific community, supplying a range of products from almost 30 principals including globally recognized brands like Cytiva, Agilent, PacBio, Nanostring, Cell Signaling Technologies, Proteintech, Twist Bioscience, Quanterix, Thermo Fisher and others.

RI also supplies Pure-NA and True-Pro, their own brand of reagents and consumables for genomics and protein research. RI currently employs over 70 people in 4 countries who provide a full suite of services including sales, marketing, service and regulatory and logistical support.

The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months. The other companies, Medigene Sdn Bhd, Analisa Resources Sdn Bhd and Scientific Resources Pte Ltd, are well-established players in clinical diagnostics, analytical and life sciences with portfolios highly complementary to RI's.

In Singapore, where RI headquarters are located, the government has identified research and development as a strategic priority since the 1990s, and continues to be a key pillar of Singapore's plan to be an innovation-driven and knowledge-based economy.